ArticlePloS one2018

Correction: The sorafenib anti-relapse effect after alloHSCT is associated with heightened alloreactivity and accumulation of CD8+PD-1+ (CD279+) lymphocytes in marrow.

Andrzej Lange et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.